Stock-Based Compensation (Tables)
|
12 Months Ended |
Jan. 31, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Summary of Stock Option Activity |
A summary of stock option activity as of and for the fiscal year ended January 31, 2026 under the Plans is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options Outstanding Under the Plans | | Weighted Average Exercise Price | | Weighted Average
Remaining Contractual
Term (Years) | | Aggregate
Intrinsic Value
(in thousands) | | Outstanding at January 31, 2025* | 31,132,993 | | | $ | 1.94 | | | 3.8 | | 376,555 | | | | | | | | | | | | | | | | | | Exercised | (6,649,247) | | | 2.06 | | | | | 79,613 | | | Expired | (709,006) | | | 2.36 | | | | | | Forfeited | (19,375) | | | 2.91 | | | | | | | Outstanding at January 31, 2026* | 23,755,365 | | | 1.90 | | | 3.2 | | $ | 161,131 | | | Exercisable at January 31, 2026 | 23,685,819 | | | $ | 1.90 | | | 3.2 | | $ | 160,702 | |
______________ *The Plans allow for early exercise of stock options and exercised/forfeited balances include only vested stock options exercised.
|
| Schedule of Nonvested Stock Option Activity |
| | | | | | | | | | | | | Shares | | Weighted-Average Grant-Date Fair Value | | Unvested at January 31, 2025 | 308,493 | | | $ | 4.50 | | | Granted | — | | | — | | | Vested | (214,905) | | | 4.40 | | | Forfeited | (19,375) | | | 4.73 | | | Unvested at January 31, 2026 | 74,213 | | | $ | 4.73 | |
|
| Summary of Restricted Stock Activity |
A summary of RSU activity for the fiscal year ended January 31, 2026 under the Plans is as follows: | | | | | | | | | | | | | Number of Shares | | Weighted Average Grant Date Fair Value | | Outstanding at January 31, 2025 | 31,294,850 | | | $ | 8.23 | | | Granted | 7,281,903 | | | 14.21 | | | Settled | (21,640,347) | | | 7.05 | | | Forfeited | (1,260,251) | | | 8.01 | | | Outstanding at January 31, 2026 | 15,676,155 | | | $ | 12.51 | |
|
| Allocation of Stock-Based Compensation |
Stock-based compensation expense recognized in the consolidated statements of operations for the fiscal year ended January 31, 2026, 2025, and 2024 was as follows (in thousands): | | | | | | | | | | | | | | | | | | | Fiscal Year Ended January 31, | | 2026 | | 2025 | | 2024 | | Product development | $ | 127,414 | | | $ | 7,325 | | | $ | 8,692 | | | General and administrative | 110,677 | | | 2,041 | | | 2,647 | | | Marketing | 8,472 | | | 536 | | | 582 | | | Operations and support | 13,261 | | | 1,099 | | | 1,334 | | | Total stock-based compensation expense | 259,824 | | | 11,001 | | | 13,255 | | | Capitalized stock-based compensation expense | — | | | (1,637) | | | (1,409) | | | Total stock-based compensation expense, net of amounts capitalized | $ | 259,824 | | | $ | 9,364 | | | $ | 11,846 | |
|